S
Shuya Lu
Researcher at University of Electronic Science and Technology of China
Publications - 5
Citations - 81
Shuya Lu is an academic researcher from University of Electronic Science and Technology of China. The author has contributed to research in topics: Randomized controlled trial & Relative risk. The author has an hindex of 2, co-authored 5 publications receiving 45 citations. Previous affiliations of Shuya Lu include Lanzhou University.
Papers
More filters
Journal ArticleDOI
Effectiveness and safety of glucocorticoids to treat COVID-19: A rapid review and meta-analysis
Shuya Lu,Qi Zhou,Liping Huang,Qianling Shi,Siya Zhao,Zijun Wang,Weiguo Li,Yuyi Tang,Yanfang Ma,Xufei Luo,Toshio Fukuoka,Hyeong Sik Ahn,Myeong Soo Lee,Zhengxiu Luo,Enmei Liu,Yaolong Chen,Chenyan Zhou,Chenyan Zhou,Donghong Peng +18 more
TL;DR: Glucocorticoid therapy was found to reduce the duration of fever, but not mortality, duration of hospitalization or lung inflammation absorption, so routine use of systemic glucocortioids for patients with COVID-19 cannot be recommend.
Journal ArticleDOI
Mortality and Clinical Interventions in Critically ill Patient With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
TL;DR: Wang et al. as discussed by the authors summarized the current existing evidence on the outcome of critically ill patients with COVID-19 as well as to evaluate the effectiveness of clinical interventions, including invasive mechanical ventilation, kidney replacement therapy, and vasopressor.
Journal ArticleDOI
Potential effectiveness and safety of antiviral agents in children with coronavirus disease 2019: A rapid review and meta-analysis
Qianling Shi,Qi Zhou,Xia Wang,Jing Liao,Yang Yu,Zijun Wang,Shuya Lu,Yanfang Ma,Yangqin Xun,Xufei Luo,Weiguo Li,Toshio Fukuoka,Hyeong Sik Ahn,Myeong Soo Lee,Zhengxiu Luo,Enmei Liu,Yaolong Chen,Qubei Li,Kehu Yang,Quanlin Guan +19 more
TL;DR: There is no evidence showing the effectiveness of antiviralagents for children with COVID-19, and the clinical efficacy of existing antiviral agents is still uncertain, and it is do not suggest clinical routine use of antivirals for CO VID-19 in children, with the exception of clinical trials.
Posted ContentDOI
Potential Effectiveness and Safety of Antiviral Agents in Children with Coronavirus Disease 2019: A Rapid Review and Meta-Analysis
Qianling Shi,Qi Zhou,Xia Wang,Jing Liao,Yang Yu,Zijun Wang,Shuya Lu,Yanfang Ma,Yangqin Xun,Xufei Luo,Weiguo Li,Toshio Fukuoka,Hyeong Sik Ahn,Myeong Soo Lee,Zhengxiu Luo,Enmei Liu,Yaolong Che,Qubei Li,Kehu Yang +18 more
TL;DR: There is no evidence showing the effectiveness of antiviral agents for children with COVID-19, and the clinical efficacy of existing antiviralagents is still uncertain.
Journal ArticleDOI
Reporting quality evaluation of the stroke clinical practice guidelines: a systematic review
Shuya Lu,Shuya Lu,Xufei Luo,Xiaojia Ni,Haoxuan Li,Miaomiao Meng,Yefeng Cai,Yunlan Liu,Mengjuan Ren,Yanrui Sun,Yaolong Chen +10 more
TL;DR: Wang et al. as discussed by the authors analyzed the effectiveness and quality of stroke clinical practice guidelines (CPGs) published in recent years in order to guide future guideline developers to develop better guidelines.